Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cornea
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cornea
    TopAbstracts in Cornea 11/17/2008 - (DGNews)
    TopAbstracts in Cornea 10/20/2008 - (DGNews)
    TopAbstracts in Cornea 09/22/2008 - (DGNews)
    TopAbstracts in Cornea 08/25/2008 - (DGNews)
    TopAbstracts in Cornea 07/28/2008 - (DGNews)

    News archive

     Recent webcasts/CME

      Webcasts/CME archive

       Recent cases - Cornea
        Femtosecond Laser Astigmatic Keratotomy for Postkeratoplasty Astigmatism
        Clinical and Pathological Report of an Unusual Anterior Chamber Lesion: A Case Report
        Optic Atrophy, Necrotizing Anterior Scleritis and Keratitis Presenting in Association with Streptococcal Toxic Shock Syndrome: A Case Report
        Congenital Corneal Staphyloma Treated by Evisceration and Primary Implant Placement: 3 Cases
        Spontaneous Corneal Melting in Pregnancy: A Case Report

        Cases archive
          




        my personal edition > cornea > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Preservative-Free Diclofenac Sodium Effective In Vernal Keratoconjunctivitis

        A DGReview of :"Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis"
        Graefe's Archive for Clinical and Experimental Ophthalmology

        04/16/2003
        By Mark Greener


        Preservative-free diclofenac sodium 0.1% eye drops are effective and safe in controlling the signs and symptoms of vernal keratoconjunctivitis, according to study findings.

        Researchers from University of Rome "Tor Vergata" and other Italian centres enrolled 22 patients into their prospective open study. All patients had vernal keratoconjunctivitis. They applied preservative-free diclofenac sodium 0.1% drops in both eyes, four times a day, for 120 days.

        At the end of treatment, 40% of patients showed improvement in the symptoms of vernal keratoconjunctivitis, namely itching, redness and photophobia. Moreover, the total sign (papillae, hyperaemia and corneal lesions) and symptoms scores were lower at the end of treatment compared to baseline. Conjunctival redness and hyperaemia, itching and photophobia all declined by the end of treatment.

        Corneal lesions and papillary size did not change, however, and no patient experienced an exacerbation of vernal keratoconjunctivitis during treatment with diclofenac sodium.

        The authors commented that the study is preliminary. They did conclude, however, that prolonged use of preservative-free diclofenac sodium 0.1% eye drops is effective and safe in controlling the signs and symptoms of vernal keratoconjunctivitis.
        Graefe's Arch Clin Exp Ophthalmol 2003;241:192-195. "Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send